Home
>
National Drug Code (NDC)
>
ABILIFY
ABILIFY - 59148-016-65 - (ARIPIPRAZOLE)
Drug Information of ABILIFY
| Product NDC: | 59148-016 |
| Proprietary Name: | ABILIFY |
| Non Proprietary Name: | ARIPIPRAZOLE |
| Active Ingredient(s): | 9.75 mg/1.3mL & nbsp; ARIPIPRAZOLE |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ABILIFY
| Product NDC: | 59148-016 |
| Labeler Name: | Otsuka America Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021866 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060920 |
Package Information of ABILIFY
| Package NDC: | 59148-016-65 |
| Package Description: | 1.3 mL in 1 VIAL (59148-016-65) |
NDC Information of ABILIFY
| NDC Code | 59148-016-65 |
| Proprietary Name | ABILIFY |
| Package Description | 1.3 mL in 1 VIAL (59148-016-65) |
| Product NDC | 59148-016 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ARIPIPRAZOLE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20060920 |
| Marketing Category Name | NDA |
| Labeler Name | Otsuka America Pharmaceutical, Inc. |
| Substance Name | ARIPIPRAZOLE |
| Strength Number | 9.75 |
| Strength Unit | mg/1.3mL |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
